Amyloid-beta is a peptide that accumulates in the brains of individuals with Alzheimer's disease, forming plaques that are a hallmark of the condition. Its aggregation is believed to disrupt cell function and trigger neurodegeneration, making it a central focus of Alzheimer's research and potential therapeutic interventions.